Showing results (2131-2140 of 2,304) with videos related to

Sort By:
Pageof 231
The European Respiratory Journal|October 21, 2009
No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 mC Dehnert, A M Luks, G Schendler, et al.
Journal of Molecular Biology|July 25, 2009
The protective antigen component of anthrax toxin forms functional octameric complexesAlexander F Kintzer, Katie L Thoren, Harry J Sterling, et al.
The Review of Scientific Instruments|March 5, 2008
Low pressure and high power rf sources for negative hydrogen ions for fusion applications (ITER neutral beam injection)U Fantz, P Franzen, W Kraus, et al.
Immuno-Oncology Technology|January 1, 2026
Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cellsM Abooali, X Lei, I M Yasinska, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 7, 2023
Methods for think-aloud interviews in health-related resource-use research: the PECUNIA RUM instrumentL M M Janssen, I Pokhilenko, R M W A Drost, et al.
ACS Chemical Biology|January 31, 2024
Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided OptimizationNicolas Bauer, Dimitrios-Ilias Balourdas, Joel R Schneider, et al.
Mechanisms of Ageing and Development|November 2, 2010
Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokinesS K Brusnahan, T R McGuire, J D Jackson, et al.
Archives of Neurology|February 11, 2009
Rate of brain atrophy in benign vs early multiple sclerosisSusan A Gauthier, Annika M Berger, Zsuzsanna Liptak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Clinical and Experimental Immunology|March 24, 2020
Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutationO Shamriz, A J Simon, A Lev, et al.
Pageof 231